AIDS and Behavior

, Volume 21, Issue 12, pp 3527–3548 | Cite as

Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions

  • Jaimie P. Meyer
  • Dharushana Muthulingam
  • Nabila El-Bassel
  • Frederick L. Altice
Substantive Review


The criminal justice (CJ) system can be leveraged to access women for HIV prevention and treatment programs. Research is lacking on effective implementation strategies tailored to the specific needs of CJ-involved women. We conducted a scoping review of published studies in English from the United States that described HIV interventions, involved women or girls, and used the CJ system as an access point for sampling or intervention delivery. We identified 350 studies and synthesized data from 42 unique interventions, based in closed (n = 26), community (n = 7), or multiple/other CJ settings (n = 9). A minority of reviewed programs incorporated women-specific content or conducted gender-stratified analyses. CJ systems are comprised of diverse access points, each with unique strengths and challenges for implementing HIV treatment and prevention programs for women. Further study is warranted to develop women-specific and trauma-informed content and evaluate program effectiveness.


HIV Intervention Criminal justice Women Systematic review Implementation science 



Research support provided by the National Institutes on Drug Abuse (K23 DA033858 to JPM; K24 DA017072 to FLA), and National Institute of Allergy and Infectious Diseases (T32 AI007517 to DM). Funding sources played no role in data collection, analysis, drafting of the manuscript, or decision to submit the manuscript for publication.

Compliance with Ethical Standards

Conflict of interest

All authors declare no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.


  1. 1.
    Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, et al. Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience. J Womens Health Gend Based Med. 2000;9(1):51–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S49–55.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Maruschak L. Bureau of justice statistics bulletin: HIV in prisons, 2007–2008. 2009.
  5. 5.
    International Centre for Prison Studies. World Prison Brief. 2014.
  6. 6.
    Jenness S, Neaigus A, Hagan H, Murrill C, Wendel T. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS. 2010;24(3):175–81.CrossRefPubMedGoogle Scholar
  7. 7.
    El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61(1):171–83.CrossRefPubMedGoogle Scholar
  8. 8.
    El-Bassel N, Witte S, Wada T, Gilbert L, Wallace J. Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDS. 2001;15(1):41–51.CrossRefPubMedGoogle Scholar
  9. 9.
    Meyer J, Altice F. HIV in injection and other drug users. Sexually transmitted infections. 2nd ed. Amsterdam: Elsevier Publications; 2011.Google Scholar
  10. 10.
    Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG. Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health. 2010;100(3):476–82.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Maruschak LM, Beaver R. HIV in Prisons, 2008. Washington, D.C.: U.S. Department of Justice, Office of Justice Programs BoJS; 2009 December 2009. Report No.: NCJ 228307 Contract No.: NCJ 228307.Google Scholar
  12. 12.
    Altice FL, Marinovich A, Khoshnood K, Blankenship KM, Springer SA, Selwyn PA. Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J Urban Health. 2005;82(2):312–26.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Strathdee SA, West BS, Reed E, Moazan B, Azim T, Dolan K. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. JAIDS. 2015;69:S110–7.PubMedPubMedCentralGoogle Scholar
  14. 14.
    World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Geneva: Switzerland; 2014.Google Scholar
  15. 15.
    The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington, D.C. 2015.Google Scholar
  16. 16.
    Centers for Disease Control and Prevention. Effective Interventions: HIV Prevention that Works. 2015.
  17. 17.
    Wolitski RJ. Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. Am J Public Health. 2006;96(10):1854–61.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Estelle v. Gamble. Sect. 429 (1976).Google Scholar
  19. 19.
    Hatcher SS, Toldson IA, Godette DC, Richardson JB. Mental health, substance abuse, and HIV disparities in correctional settings: practice and policy implications for African Americans. J Health Care Poor Underserved. 2009;20(2 Suppl):6–16.CrossRefPubMedGoogle Scholar
  20. 20.
    Springer S, Pesanti E, Hodges J, Macura T, Doros G, Altice F. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Baillargeon J, Borucki MJ, Zepeda S, Jenson HB, Leach CT. Antiretroviral prescribing patterns in the Texas prison system. Clin Infect Dis. 2000;31(6):1476–81.CrossRefPubMedGoogle Scholar
  22. 22.
    Altice F, Kamarulzaman A, Soriano V, Schechter M, Friedland G. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105(9):1901–10.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104(3):434–41.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Flanigan T, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–83.CrossRefPubMedGoogle Scholar
  27. 27.
    Lichtenstein B, Malow R. A critical review of HIV-related interventions for women prisoners in the United States. J Assoc Nurses AIDS Care. 2010;21(5):380–94.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Underhill K, Dumont D, Operario D. HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings. Am J Public Health. 2014;104(11):e27–53.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Azhar SV, Berringer KR, Epperson MW. A systematic review of HIV prevention interventions targeting women with criminal justice involvement. J Soc Soc Work Res. 2014;5(3):253–89.CrossRefGoogle Scholar
  30. 30.
    Armstrong R, Hall BJ, Doyle J, Waters E. Cochrane update. ‘Scoping the scope’ of a cochrane review. J Public Health. 2011;33(1):147–50.CrossRefGoogle Scholar
  31. 31.
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123–30.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Bureau of Justice Statistics. The justice system. 2016.
  33. 33.
    Kavasery R, Maru DS, Cornman-Homonoff J, Sylla LN, Smith D, Altice FL. Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS ONE. 2009;4(11):e7648.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community—a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011;33:436–44.CrossRefPubMedGoogle Scholar
  35. 35.
    White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, et al. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. AIDS Behav. 2015;19(1):128–36.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350–9.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Springer S, Chen S, Altice F. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Knudsen HK, Staton-Tindall M, Oser CB, Havens JR, Leukefeld CG. Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care. 2014;26(9):1071–9.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Fogel CI, Crandell JL, Neevel AM, Parker SD, Carry M, White BL, et al. Efficacy of an adapted HIV and sexually transmitted infection prevention intervention for incarcerated women: a randomized controlled trial. Am J Public Health. 2015;105(4):802–9.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Sacks JY, McKendrick K, Hamilton Z. A randomized clinical trial of a therapeutic community treatment for female inmates: outcomes at 6 and 12 months after prison release. J Addict Dis. 2012;31(3):258–69.CrossRefPubMedGoogle Scholar
  41. 41.
    St. Lawrence JS, Eldridge GD, Shelby MC, Little CE, Brasfield TL, O’Bannon IRE. HIV risk reduction for incarcerated women: a comparison of brief interventions based on two theoretical models. J Consult Clin Psychol. 1997;65(3):504–9.CrossRefPubMedGoogle Scholar
  42. 42.
    El-Bassel N, Gilbert L, Goddard-Eckrich D, Chang M, Wu E, Hunt T, et al. Efficacy of a group-based multimedia HIV prevention intervention for drug-involved women under community supervision: project WORTH. PLoS ONE. 2014;9(11):e111528.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Grinstead Reznick O, Comfort M, McCartney K, Neilands TB. Effectiveness of an HIV prevention program for women visiting their incarcerated partners: the HOME project. AIDS Behav. 2011;15(2):365–75.CrossRefPubMedGoogle Scholar
  44. 44.
    Martin SS, O’Connell DJ, Inciardi JA, Surratt HL, Maiden KM. Integrating an HIV/HCV brief intervention in prisoner reentry: results of a multisite prospective study. J Psychoact Drugs. 2008;40(4):427–36.CrossRefGoogle Scholar
  45. 45.
    Rhodes W, Gross M. Case management reduces drug use and criminality among drug-involved arrestees: an experimental study of an HIV prevention intervention. Rockville, MD: National Institute of Justice and the National Institute on Drug Abuse; 1997.Google Scholar
  46. 46.
    Straub DM, Pomputius P, Boyer CB, Someillan NS, Perrin K. HIV prevention education and testing among youth: is there a correlation? J Adolesc Health. 2007;41(1):105–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Kelly PJ, Owen SV, Peralez-Dieckmann E, Martinez E. Health interventions with girls in the juvenile justice system. Womens Health Issues. 2007;17(4):227–36.CrossRefPubMedGoogle Scholar
  48. 48.
    Mahoney M, Bien M, Comfort M. Adaptation of an evidence-based HIV prevention intervention for women with incarcerated partners: expanding to community settings. AIDS Educ Prev. 2013;25(1):1–13.CrossRefPubMedGoogle Scholar
  49. 49.
    Tolou-Shams M, Houck C, Conrad SM, Tarantino N, Stein LA, Brown LK. HIV prevention for juvenile drug court offenders: a randomized controlled trial focusing on affect management. J Correct Health Care. 2011;17(3):226–32.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Weir BW, O’Brien K, Bard RS, Casciato CJ, Maher JE, Dent CW, et al. Reducing HIV and partner violence risk among women with criminal justice system involvement: a randomized controlled trial of two motivational interviewing-based interventions. AIDS Behav. 2009;13(3):509–22.CrossRefPubMedGoogle Scholar
  51. 51.
    Springer SA, Spaulding A, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-Infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Lichtenstein B, Barber BW. A partnership approach to providing on-site HIV services for probationers and parolees: a pilot study from Alabama, USA. J Int AIDS Soc. 2016;19(4 Suppl 3):20868.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Trestman RL, Ferguson W, Dickert J. Behind bars: the compelling case for academic health centers partnering with correctional facilities. Acad Med. 2015;90(1):16–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Centers for Disease Control. HIV among women. 2016.
  55. 55.
    World Health Organization. Global health observatory data: number of women living with HIV. 2016.
  56. 56.
    El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. Lancet. 2010;376(9738):312–4.CrossRefPubMedGoogle Scholar
  57. 57.
    El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7(4):326–31.CrossRefPubMedGoogle Scholar
  58. 58.
    Williams CT, Kim S, Meyer J, Spaulding A, Teixeira P, Avery A, et al. Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail. AIDS Behav. 2013;17:195–202.CrossRefPubMedCentralGoogle Scholar
  59. 59.
    Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104:434–41.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-Related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105:e1–10.CrossRefGoogle Scholar
  61. 61.
    Belenko S, Dembo R, Copenhaver M, Hiller M, Swan H, Albizu Garcia C, et al. HIV stigma in prisons and jails: results from a staff survey. AIDS Behav. 2016;20(1):71–84.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    World Health Organization. Tool to set and monitor targets for HIV preventions, diagnosis, treatment, and care for key populations: supplement to the 2014 consolidated guidelines for HIV prevention, diagnosis, treatment, and care for key populations Geneva, Switzerland: 2015.Google Scholar
  63. 63.
    Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, et al. Implementing implementation science: an approach for HIV prevention, care and treatment programs. Curr HIV Res. 2015;13(3):244–9.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Loeliger KB, Biggs ML, Young R, Kahana SY, Seal DW, Beckwith CG, et al. Gender differences in HIV risk behaviors among persons involved in the U.S. criminal justice system and living with HIV or at risk for HIV: a “seek, test, treat, and retain” harmonization consortium. AIDS Behav. 2017; In press.Google Scholar
  65. 65.
    Bryan AD, Schmiege SJ, Broaddus MR. HIV risk reduction among detained adolescents: a randomized, controlled trial. Pediatrics. 2009;124(6):e1180–8.CrossRefPubMedGoogle Scholar
  66. 66.
    DiClemente RJ, Davis TL, Swartzendruber A, Fasula AM, Boyce L, Gelaude D, et al. Efficacy of an HIV/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: a randomized controlled trial. Women Health. 2014;54(8):726–49.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    El-Bassel N, Ivanoff A, Schilling RF, Gilbert L, Borne D, Chen DR. Preventing HIV/AIDS in drug-abusing incarcerated women through skills building and social support enhancement: preliminary outcomes. Soc Work Res. 1995;19(3):131–41.PubMedGoogle Scholar
  68. 68.
    Fasula AM, Fogel CI, Gelaude D, Carry M, Gaiter J, Parker S. Project power: adapting an evidence-based HIV/STI prevention intervention for incarcerated women. AIDS Educ Prev. 2013;25(3):203–15.CrossRefPubMedGoogle Scholar
  69. 69.
    Fogel CI, Gelaude DJ, Carry M, Herbst JH, Parker S, Scheyette A, et al. Context of risk for HIV and sexually transmitted infections among incarcerated women in the south: individual, interpersonal, and societal factors. Women Health. 2014;54(8):694–711.CrossRefPubMedGoogle Scholar
  70. 70.
    Havens JR, Leukefeld CG, Oser CB, Staton-Tindall M, Knudsen HK, Mooney J, et al. Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. J Exp Criminol. 2009;5(3):245–72.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Leukefeld C, Havens J, Tindall MS, Oser CB, Mooney J, Hall MT, et al. Risky relationships: targeting HIV prevention for women offenders. AIDS Educ Prev. 2012;24(4):339–49.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Myers J, Zack B, Kramer K, Gardner M, Rucobo G, Costa-Taylor S. Get connected: an HIV prevention case management program for men and women leaving California prisons. Am J Public Health. 2005;95(10):1682–4.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Needels K, James-Burdumy S, Burghardt J. Community case management for former jail inmates: its impacts on rearrest, drug use, and HIV risk. J Urban Health. 2005;82(3):420–33.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Richie BE, Freudenberg N, Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001;78(2):290–303.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Robertson AA, St Lawrence J, Morse DT, Baird-Thomas C, Liew H, Gresham K. The healthy teen girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav. 2011;38(3):241–50.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Schlapman N, Cass PS. Project: HIV prevention for incarcerated youth in Indiana. J Community Health Nurs. 2000;17(3):151–8.CrossRefPubMedGoogle Scholar
  77. 77.
    Schmiege SJ, Broaddus MR, Levin M, Bryan AD. Randomized trial of group interventions to reduce HIV/STD risk and change theoretical mediators among detained adolescents. J Consult Clin Psychol. 2009;77(1):38–50.CrossRefPubMedGoogle Scholar
  78. 78.
    Schmiege SJ, Feldstein Ewing SW, Hendershot CS, Bryan AD. Positive outlook as a moderator of the effectiveness of an HIV/STI intervention with adolescents in detention. Health Educ Res. 2011;26(3):432–42.CrossRefPubMedGoogle Scholar
  79. 79.
    Scott CK, Dennis ML. The first 90 days following release from jail: findings from the recovery management checkups for women offenders (RMCWO) experiment. Drug Alcohol Depend. 2012;125(1–2):110–8.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    St. Lawrence JS, Eldridge GD, Shelby MC, Little CE, Brasfield TL, O’Bannon IRE. HIV risk reduction for incarcerated women: A comparison of brief interventions based on two theoretical models. Journal of Consulting and Clinical Psychology. 1997;65(3):504–9.Google Scholar
  81. 81.
    Vigilante KC, Flynn MM, Affleck PC, Stunkle JC, Merriman NA, Flanigan TP, et al. Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. J Womens Health. 1999;8(3):409–15.CrossRefPubMedGoogle Scholar
  82. 82.
    Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014;39(2):256–68.CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Springer SA, Brown SE, Di Paola A. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015;157:158–65.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Kim JY, Rich J, Zierler S, Lourie K, Vigilante K, Normandie L, et al. Successful community follow-up and reduced recidivism in HIV positive women prisoners. J Correct Health Care. 1997;4(1):5–17.CrossRefGoogle Scholar
  85. 85.
    MacGowan RJ, Lifshay J, Mizuno Y, Johnson WD, McCormick L, Zack B. Positive transitions (POST): evaluation of an HIV prevention intervention for HIV-positive persons releasing from correctional facilities. AIDS Behav. 2015;19(6):1061–9.CrossRefPubMedGoogle Scholar
  86. 86.
    Pomeroy EC, Kiam R, Abel EM. The effectiveness of a psychoeducational group for HIV-infected/affected incarcerated women. Res Soc Work Pract. 1999;9(2):171–87.CrossRefGoogle Scholar
  87. 87.
    Reznick OG, McCartney K, Gregorich SE, Zack B, Feaster DJ. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. J Correct Health Care. 2013;19(3):178–93.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - A potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011.Google Scholar
  89. 89.
    Altice F, Saber-Tehrani A, Qiu J, Herme M. Abstract #543: DAART is superior to self-administered therapy among released HIV+ prisoners: results from a randomized controlled trial. Boston: CROI; 2011.Google Scholar
  90. 90.
    Wohl DA, Scheyett A, Golin CE, White B, Matuszewski J, Bowling M, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–64.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Zaller ND, Holmes L, Dyl AC, Mitty JA, Beckwith CG, Flanigan TP, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.CrossRefPubMedGoogle Scholar
  92. 92.
    Alemagno SA, Stephens RC, Stephens P, Shaffer-King P, White P. Brief motivational intervention to reduce HIV risk and to increase HIV testing among offenders under community supervision. J Correct Health Care. 2009;15(3):210–21.CrossRefPubMedGoogle Scholar
  93. 93.
    Brown R, Gassman M, Hetzel S, Berger L. Community-based treatment for opioid dependent offenders: a pilot study. Am J Addict. 2013;22(5):500–2.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Nydegger LA, Keeler AR, Hood C, Siegel JT, Stacy AW. Effects of a one-hour intervention on condom implementation intentions among drug users in Southern California. AIDS Care. 2013;25(12):1586–91.CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Prendergast M, Frisman L, Sacks JY, Staton-Tindall M, Greenwell L, Lin HJ, et al. A multi-site, randomized study of strengths-based case management with substance-abusing parolees. J Exp Criminol. 2011;7(3):225–53.CrossRefPubMedPubMedCentralGoogle Scholar
  97. 97.
    Grinstead O, Comfort M, McCartney K, Koester K, Neilands T. Bringing it home: Design and implementation of an HIV/STD intervention for women visiting incarcerated men. AIDS Educ Prev. 2008;20(4):285–300.CrossRefPubMedGoogle Scholar
  98. 98.
    Mallory C, Hesson-McInnis M. Pilot test results of an HIV prevention intervention for high-risk women. West J Nurs Res. 2013;35(3):313–29.CrossRefPubMedGoogle Scholar
  99. 99.
    Rhodes W, Gross M. Case Management Reduces Drug Use and Criminality Among Drug-Involved Arrestees: An Experimental Study of an HIV Prevention Intervention. Rockville, MD: 1997.Google Scholar
  100. 100.
    Hser YI, Fu L, Wu F, Du J, Zhao M. Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. J Subst Abuse Treat. 2013;44(1):78–83.CrossRefPubMedGoogle Scholar
  101. 101.
    Goldberg E, Millson P, Rivers S, Manning SJ, Leslie K, Read S, et al. A human immunodeficiency virus risk reduction intervention for incarcerated youth: a randomized controlled trial. J Adolesc Health. 2009;44(2):136–45.CrossRefPubMedGoogle Scholar
  102. 102.
    Gilbert L, Goddard-Eckrich D, Hunt T, Ma X, Chang M, Rowe J, et al. Efficacy of a computerized intervention on HIV and intimate partner violence among substance-using women in community corrections: a randomized controlled trial. Am J Public Health. 2016;106:e1–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Jaimie P. Meyer
    • 1
  • Dharushana Muthulingam
    • 2
  • Nabila El-Bassel
    • 3
  • Frederick L. Altice
    • 1
    • 4
    • 5
  1. 1.AIDS ProgramYale School of MedicineNew HavenUSA
  2. 2.Section of Infectious DiseasesYale School of MedicineNew HavenUSA
  3. 3.Columbia School of Social WorkNew YorkUSA
  4. 4.Yale School of Public HealthNew HavenUSA
  5. 5.University of MalayaKuala LumpurMalaysia

Personalised recommendations